ライフサイエンスコーパス: RISC

1 RISC-formation is dependent on a shared pool of Argonaut

2 RISC-sequencing is a highly sensitive method for general

3 RISCs represent a critical checkpoint in the regulation

4 infection and decreased fast (1,241 and 141 RISC-bound genes at 7 h and 10 h post-infection, respect

5 r operating characteristic curve were 0.791 (RISC) and 0.783 (Botnia), similar in accuracy when subst

6 Our data demonstrate that a RISC-like complex mediates the stability of HCV RNA and

7 n brain-infiltrating T lymphocytes, aberrant RISC formation contributed to miRNA-dependent proinflamm

8 nd the amount of siRNA at its site of action RISC (RNA-induced silencing complex) were evaluated usin

9 Active RISC is a multiple-turnover enzyme that uses the guide s

10 2 binds efficiently to miRNAs forming active RISC.

11 ind that recombinant mouse Ago2 forms active RISC using pre-miRNAs or long unstructured single strand

12 eaved products to assemble or restore active RISC.

13 ger (or sense) strand to generate the active RISC complex.

14 go, presents a logical opportunity to affect RISC's activity.

15 small RNA (sRNA) duplexes onto specific Ago-RISCs.

16 transcripts in a process which involves Ago1/RISC and P-bodies.

17 single-turnover cleavage rates of mouse AGO2 RISC.

18 lish that CryAB is necessary for normal Ago2/RISC activity and cellular homeostasis in skeletal muscl

19 eduction that is independent of both Ago and RISC.

20 tetramerization to enhance siRNA binding and RISC loading activities.

21 ingspot Virus, as well as by human Dicer and RISC assembly complexes.

22 t on a shared pool of Argonaute proteins and RISC-loading factors, and is susceptible to competition

23 We observed both siRNA and siRNA- and RISC-dependent silencing of the target gene GFP.

24 ggesting that they, or their precursors, are RISC targeted.

25 t the small RNAs, although less efficient at RISC-formation, can perform in the low RISC-recycling ra

26 ry protein of the argonaute (AGO2)-miR-33a/b-RISC complex, as it directly binds to miR-33a/b, AGO2, a

27 strand (target complementary strand), better RISC assembly, persistence of the guide strand and relat

28 earning accelerator components, and a 32-bit RISC-V ALU, based on our developed standard cell library

29 ight-regulation of catalytic RNA cleavage by RISC and the light-regulation of seed region recognition

30 iscuss that small RNA activity is limited by RISC-formation, RISC-degradation, and the availability o

31 nscripts can be translationally repressed by RISCs without substantial messenger RNA (mRNA) destabili

32 them recurrence-initiating stem-like cancer (RISC) cells.

33 comparing RNA-sequencing results of cardiac RISC and transcriptome from the same individual hearts,

34 mRNAs consistently targeted to mouse cardiac RISCs.

35 In most cases, RISC inhibits mRNA translation through the 3'-untranslat

36 efrail-robust, prefrail-frail, and frail; CD-RISC was categorized using population norms as: least, l

37 ing the Connor-Davidson Resilience Scale (CD-RISC).

38 fectively mimic the function of the cellular RISC machinery for inducing target RNA cleavage.

39 miRNA levels; but also increased 5' cleavage RISC fragments with extended uridine tails.

40 of whether an endonucleolytically competent RISC is formed.

41 ensable for Ago loading of slicing-competent RISC.

42 1, a subunit of the miRNA regulatory complex RISC, has been implicated as an oncogene in hepatocellul

43 1) within the RNA-induced silencing complex (RISC) [19, 20].

44 whether the miRNA-induced silencing complex (RISC) acts primarily to reduce translation or stability

45 onents of the RNA-induced silencing complex (RISC) Ago2, GW182, and PABPC1, as well as a set of 522 m

46 ee siRNA from RNA-induced silencing complex (RISC) and Argonaute 2 (Ago2) associated with therapeutic

47 iRNAs) by the RNA-induced silencing complex (RISC) and its precursor, the RISC loading complex (RLC),

48 s to form the RNA-induced silencing complex (RISC) and used as guides to identify complementary trans

49 During RNA-induced silencing complex (RISC) assembly the guide (or antisense) strand has to se

50 ne silencing, RNA-induced silencing complex (RISC) assembly, stability and Argonaute (Ago) loading as

51 CLIP) for the RNA-induced silencing complex (RISC) component AGO2 and global miRNA depletion to ident

52 ranscripts to RNA-induced silencing complex (RISC) components and to cytoplasmic processing bodies.

53 The RNA induced silencing complex (RISC) contains at its core the endonuclease Argonaute (A

54 e cytoplasmic RNA-induced silencing complex (RISC) contains dsRNA binding proteins, including protein

55 clease in the RNA-induced silencing complex (RISC) facilitating RNAi-mediated gene silencing, as an A

56 Furthermore, RNA-induced silencing complex (RISC) immunoprecipitation and biotin-labeled miR-665 pul

57 RNA-induced silencing complex (RISC) is composed of miRNAs and AGO proteins.

58 tion with the RNA-induced silencing complex (RISC) is compromised in MDD.

59 n between the RNA-induced silencing complex (RISC) loaded with primary small interfering RNAs (siRNAs

60 ated with the RNA induced silencing complex (RISC) machinery.

61 onents of the RNA-induced silencing complex (RISC) mediate the biogenesis of RNAs other than miRNA.

62 aute 2 in the RNA-induced silencing complex (RISC) of cyclosporine A (CsA) treated and control human

63 rgeted by the RNA-induced silencing complex (RISC) remains controversial.

64 sembly of the RNA-induced silencing complex (RISC) requires formation of the RISC loading complex (RL

65 Nase H or the RNA-induced silencing complex (RISC) result in enzymatic degradation of target RNA.

66 uction of the RNA-induced silencing complex (RISC) scaffold protein GW182.

67 n through the RNA-induced silencing complex (RISC) that consists of one of four mammalian Argonaute p

68 rotein in the RNA Induced Silencing Complex (RISC) that silences messenger RNAs on a sequence-specifi

69 1, guides the RNA-induced silencing complex (RISC) to c-Myc mRNA and mediates the degradation of the

70 ated into the RNA-induced silencing complex (RISC) to guide degradation of the corresponding viral RN

71 them into the RNA-induced silencing complex (RISC) to guide the cleavage of complementary viral RNA.

72 directing the RNA-induced silencing complex (RISC) to their sequence-specific mRNA target(s).

73 er direct the RNA-induced silencing complex (RISC) to transcriptional and developmental regulators, i

74 ated into the RNA-induced silencing complex (RISC) where they interact with mRNAs to negatively regul

75 ated with the RNA-induced silencing complex (RISC) which is required for processing mature and biolog

76 lation of the RNA-induced silencing complex (RISC), a core component of RNAi.

77 onents of the RNA-induced silencing complex (RISC), and colocalize with a subset of these proteins to

78 ponent of the RNA-induced silencing complex (RISC), can be recruited to SGs as well as P-bodies (PBs)

79 iated by Ago2/RNA-induced silencing complex (RISC), certain siRNAs have also been demonstrated to dir

80 ponent of the RNA-induced silencing complex (RISC), has been shown to be important in modulating miR-

81 component of RNA-induced silencing complex (RISC), has been viewed as a cytoplasmic protein.

82 aded into the RNA-induced silencing complex (RISC), suggesting microRNA targeting.

83 ther form the RNA-induced silencing complex (RISC), the central effector of RNA interference (RNAi).

84 aded into the RNA-induced silencing complex (RISC), the key effector of miRNA function.

85 athway is the RNA-induced silencing complex (RISC), wherein Argonaute2 (Ago2) is essential for siRNA-

86 (RNAi) is the RNA-induced silencing complex (RISC), wherein the endoribonuclease Argonaute and single

87 heart of the RNA-induced silencing complex (RISC), wherein they use small RNA guides to recognize ta

88 NAs) form the RNA-induced silencing complex (RISC), which represses target RNA expression.

89 RNAs form the RNA-induced silencing complex (RISC), which targets mRNAs for translational silencing a

90 ex called the RNA-induced silencing complex (RISC), which, in mammals, contains at its center one of

91 eraction with RNA-induced silencing complex (RISC)-associated AGO1/AGO2.

92 recruiting an RNA-induced silencing complex (RISC)-like complex containing argonaute 2 (Ago2) to the

93 udy shows how RNA-induced silencing complex (RISC)-mediated posttranscriptional regulation of chromat

94 ted in miRNA- RNA-induced silencing complex (RISC)-messengerRNA (mRNA) complexes.

95 ponent of the RNA-induced silencing complex (RISC).

96 trolled by an RNA-induced silencing complex (RISC).

97 onents of the RNA-induced silencing complex (RISC).

98 onents of the RNA-induced silencing complex (RISC).

99 s part of the RNA-induced silencing complex (RISC).

100 onents of the RNA-induced silencing complex (RISC).

101 ponent of the RNA-induced silencing complex (RISC).

102 diated by the RNA-induced silencing complex (RISC).

103 tion into the RNA-induced silencing complex (RISC).

104 293-specified RNA-induced silencing complex (RISC).

105 (RNAi) is the RNA-induced silencing complex (RISC).

106 ponent of the RNA-induced silencing complex (RISC).

107 mbled into an RNA-induced silencing complex (RISC).

108 s to form the RNA-induced silencing complex (RISC).

109 hAgo2) of the RNA-induced silencing complex (RISC).

110 orking of the RNA-induced silencing complex (RISC).

111 RNA-dependent RNA-induced silencing complex (RISC).

112 ficity to the RNA-induced silencing complex (RISC).

113 ed within the RNA-induced silencing complex (RISC).

114 graded by the RNA-induced silencing complex (RISC).

115 active in the RNA-induced silencing complex (RISC).

116 n mediated by RNA-induced silencing complex (RISC).

117 age mediated by the Argonaute:guide complex, RISC.

118 apping complex, the CPEB repression complex, RISC, and the CCR4/NOT complex.

119 ociate with RNA-induced silencing complexes (RISC).

120 go2-centred RNA-induced silencing complexes (RISCs) and augments Ago2-dependent RNAi and miRNA biogen

121 to specific RNA-induced silencing complexes (RISCs) and differentially regulate distinct mRNA targets

122 semble into RNA-induced silencing complexes (RISCs) and localize to cytoplasmic substructures called

123 orated into RNA-induced silencing complexes (RISCs) before targeting transcripts with varying degrees

124 (miRNPs) or RNA-induced silencing complexes (RISCs) is essential for the function of miRNAs and initi

125 ed into the RNA-induced silencing complexes (RISCs) that contain Argonaute-family proteins and guide

126 constitute RNA-induced silencing complexes (RISCs) to regulate gene expression at transcriptional or

127 exes called RNA-induced silencing complexes (RISCs), which can be programmed to target virtually any

128 an form the RNA-induced silencing complexes (RISCs), which mediate RNA interference (RNAi).

129 xes, termed RNA-induced silencing complexes (RISCs), which regulate complementary transcripts by tran

130 ins to form RNA-induced silencing complexes (RISCs).

131 lencing are RNA-induced silencing complexes (RISCs).

132 ing to form RNA-induced silencing complexes (RISCs).

133 ues of Argonaute2 and Argonaute4 compromised RISC assembly.

134 interacts directly with the miRNA-containing RISC to enhance post-transcriptional inhibition.

135 res, where the reverse intersystem crossing (RISC) from triplet to singlet exciplex diminishes, a pro

136 nglets through reverse intersystem crossing (RISC) rival the efficiencies of phosphorescent state-of-

137 Here, we show that the cytoplasmic RISC proteins PACT, TRBP, and Dicer are steroid receptor

138 ulin Sensitivity and Cardiovascular Disease (RISC) study and 2,580 from the Botnia Prospective Study,

139 PLEKHA7 knockdown dissociates RISC from the ZA, decreases loading of the ZA-associated

140 During RISC maturation, the miRNA/miRNA* duplex associates with

141 sing of siRNA thermodynamic asymmetry-during RISC loading in humans.

142 -0.85] and 0.67 [0.54-0.84]) of dysglycemia (RISC) or type 2 diabetes (Botnia), independent of famili

143 sis is inhibited in response to dysregulated RISC assembly, allowing these cells to maintain a highly

144 A with most predicted targets among enriched RISC-bound genes, no effects on surface markers, cytokin

145 echanisms of gene silencing known to exploit RISC activity.

146 miRNAs by limiting their bioavailability for RISC loading and suggest a processing-independent mechan

147 to understand how small RNA competition for RISC-formation affects target gene repression.

148 ow that different competition conditions for RISC-loading result in different signatures of RNAi dete

149 hese data, we derive quantitative models for RISC binding and target cleavage and show that our in vi

150 l RNA activity is limited by RISC-formation, RISC-degradation, and the availability of Argonautes.

151 acilitating the release of cleaved mRNA from RISC.

152 ect the passenger strand and form functional RISC complexes.

153 ducts of AGO cleavage to maintain functional RISC.

154 converged domains to complete the functional RISC structure.

155 ing is a highly sensitive method for general RISC profiling and individual miR target identification

156 ytes (SCs) of EAE mic, and found that global RISC protein levels were significantly dysregulated.

157 contain Argonaute-family proteins and guide RISC to target RNAs via complementary base pairing, lead

158 ions of low RISC-loading efficiency and high RISC-recycling, the variation in target levels increases

159 Correspondingly, significantly higher RISC activity was observed in human HCC cells compared t

160 weight RNA-induced silencing complexes (HMW-RISC) associated with target mRNA.

161 increased the assembly of microRNAs into HMW-RISC, enhanced expression of the glycine-tryptophan prot

162 in of 182 kDa, an essential component of HMW-RISC, and improved the ability of microRNAs to repress p

163 The molecular mechanism for how RISC and microRNAs selectively and reversibly regulate m

164 IC-RISC(TM) extends current qualitative clinical practice g

165 evelop an online educational tool, termed IC-RISC(TM), for providers and patients to estimate more pr

166 this to anti-Argonaute 2 immunoprecipitated RISCs (RISC-Seq) from mouse hearts.

167 We observe either impaired RISC formation or increased binding of AGO2 to mRNA targ

168 In parallel with alterations in RISC complex content in OLs, we found downregulation of

169 oplex, diminished the siRNA concentration in RISC, and retarded the mRNA knockdown.

170 Guide strands detected in RISC by AGO2 immuno-isolation represented 16% of total 5

171 Eight miRNAs were highly enriched in RISC of both control and infected cells with no evidence

172 nrichment or depletion of expressed genes in RISC.

173 , since interacting proteins are involved in RISC function during RNA silencing.

174 e PIWI/MID domain of an Argonaute protein in RISC.

175 served PAZ domain plays an important role in RISC activation, providing new mechanistic insights into

176 cleaved target mRNAs and miRNA stability in RISC.

177 d from pre-RISC and may be the final step in RISC assembly, ultimately enhancing target messenger RNA

178 cks participation of the passenger strand in RISC-mediated target down-regulation with a concomitant

179 ts in GWAS meta-analyses (GENESIS [including RISC, EUGENE2, and Stanford], MAGIC, and DIAGRAM).

180 Increased RISC activity, conferred by AEG-1 or SND1, resulted in i

181 ssion of AEG-1 and SND1 leading to increased RISC activity might contribute to hepatocarcinogenesis.

182 These structures are critical for initial RISC interactions since they partially lack intramolecul

183 ble-stranded RNA- and duplex siRNA-initiated RISC activities with the use of recombinant Drosophila D

184 sembly and function of the small interfering RISC without significantly affecting the expression of m

185 tes with components of the small interfering RISC, including Argonaute 2, both in flies and in humans

186 ded small-RNA duplexes are incorporated into RISC (pre-RISC) and then become single-stranded (mature

187 ssing is not required for incorporation into RISC or potent target silencing.

188 icroRNAs is stable and can be recruited into RISC complexes subsequent to mitogenic stimulation.

189 loading of the full-length guide strand into RISC with resultant mRNA cleavage at a defined site.

190 Consequently, a high k(RISC) of 2.36 x 10(6) s(-1) with an emission peak of 456

191 om low reverse intersystem crossing rates (k(RISC) ) with emission peaks <470 nm.

192 PUM binding sites that would normally limit RISC accessibility, but would be more accessible to miRN

193 RNAs in primary T cells were enriched in LMW-RISC.

194 microRNAs in low molecular weight RISC (LMW-RISC) not bound to mRNA, suggesting that these microRNAs

195 c-Myc expression by recruiting let-7-loaded RISC (RNA miRNA-induced silencing complex) to the c-Myc

196 lly, we predict that under conditions of low RISC-loading efficiency and high RISC-recycling, the var

197 nt at RISC-formation, can perform in the low RISC-recycling range as well as their more effective cou

198 that, unlike in lower eukaryotes, mammalian RISC is not antiviral in some contexts, but rather RISC

199 In mature RISC, a single-stranded miRNA directs the Argonaute prot

200 rring rapidly, this ensures that only mature RISC would be recruited for silencing.

201 ISC) and then become single-stranded (mature RISC), a process that is not well understood.

202 hannel that appeared to stabilize the mature RISC.

203 Here, we used the human Ago2 minimal RISC system to purify Sjogren's syndrome antigen B (SSB)

204 tudies provide a comprehensive view of miRNP/RISC assembly pathways in mammals, and our assay provide

205 Here, we report an in vitro miRNP/RISC assembly assay programmed by pre-miRNAs from mammal

206 ted cells, where it interacts with the MOV10 RISC complex RNA helicase, suggesting a role for IRAV in

207 eing the rate-limiting step with noncleaving RISC.

208 The ability of RISC to locate target RNAs has been co-opted by evolutio

209 C3PO promotes the activation of RISC by degrading the Argonaute2 (Ago2)-nicked passenger

210 res of RNAi determined also by the amount of RISC-recycling taking place.

211 Analysis of RISC-loaded microRNAs using a high-throughput platform,

212 datasets, as obtained from the comparison of RISC proteins inhibition and immunoprecipitation experim

213 confirmed that AEG-1 is also a component of RISC and both AEG-1 and SND1 are required for optimum RI

214 In Arabidopsis, a key component of RISC is ARGONAUTE1 (AGO1), which not only binds to siRNA

215 nderstanding of the sequence determinants of RISC binding and cleavage.

216 ombinant Dicer and inhibits the formation of RISC-related assembly complexes found in human cell extr

217 We performed the immunoprecipitation of RISC (RNA-induced Silencing Complex) followed by microar

218 s reinstated following acute inactivation of RISC and it correlates with loss of stemness markers and

219 MAVS and RNaseL, contribute to inhibition of RISC.

220 rovided additional insights into kinetics of RISC loading and demonstrated excellent translation to n

221 vary widely, by >100-fold, in their level of RISC association and show that the level of Ago binding

222 Moreover, the level of RISC association could be modulated by overexpression of

223 ether, these data indicate that the level of RISC association of a given endogenous miRNA is regulate

224 similar sequence showed comparable levels of RISC association in the same cell line, these varied bet

225 ch unambiguously determines the magnitude of RISC, as well as several other important photophysical p

226 tter understand the recognition mechanism of RISC and the repertoire of guide-target interactions we

227 r that we term C3PO (component 3 promoter of RISC), a complex of Translin and Trax.

228 lencing called C3PO (component 3 promoter of RISC).

229 al biochemical and biophysical properties of RISC that facilitate gene targeting and describe the var

230 ute family members, the effector proteins of RISC, could modestly increase viral infectivity.

231 orescence (TADF), is dictated by the rate of RISC, a material-dependent property that is challenging

232 o miR-125, and attenuates the recruitment of RISC by miR-125, thereby repressing the function of miR-

233 pecific microRNAs, but also on regulation of RISC assembly by intracellular signaling.

234 derlie the innate and adaptive resistance of RISC cells, and both need to be targeted to prevent glio

235 speculate that these affect the response of RISC to miRNA-target binding.

236 , there is little information on the role of RISC components in human development and organ function.

237 s to 3'UTR of c-Myc mRNA and two subunits of RISC, TRBP (HIV-1 TAR RNA-binding protein) and Ago2, med

238 Herein, the thermodynamics of RISC cofactors and targeting magnesium-rich RNA secondar

239 halomyelitis (EAE); however, the function of RISCs in EAE and MS is largely unknown.

240 g the effects of nanoparticle conjugation on RISC incorporation and subsequent gene silencing have be

241 fferential effects of these modifications on RISC loading.

242 that each miR171a strand can be loaded onto RISC with separate regulatory outcomes.

243 both AEG-1 and SND1 are required for optimum RISC activity facilitating small interfering RNA (siRNA)

244 e modifications than tolerated by RNase H or RISC-dependent ASOs, with the goal of improving ASO drug

245 n reduce gene expression via the RNase H1 or RISC pathways and can increase gene expression through m

246 ular pathogen-associated molecular patterns, RISC activity decreases, contributing to increased expre

247 Thermodynamics data show that a persistent RISC cofactor is significantly more exothermic for effec

248 functions in the formation of a stable Piwi RISC (RNA-induced silencing complex).

249 after removal of the miRNA* strand from pre-RISC and may be the final step in RISC assembly, ultimat

250 RNA duplexes are incorporated into RISC (pre-RISC) and then become single-stranded (mature RISC), a p

251 ucleotide modifications on Dicer processing, RISC loading and RNAi-mediated mRNA cleavage was investi

252 Myh6 promoter-driven precursors (programmed RISC-Seq) to identify 209 in vivo targets of miR-133a an

253 g2+-dependent endoribonuclease that promotes RISC activation by removing siRNA passenger strand cleav

254 s not antiviral in some contexts, but rather RISC has been co-opted to negatively regulate toxic host

255 o anti-Argonaute 2 immunoprecipitated RISCs (RISC-Seq) from mouse hearts.

256 Using these 2 variables, a risk score (RISC score) was derived from the regression model (area

257 Herein, we present a synthetic RISC-mimic nanocomplex, which can actively cleave its ta

258 Importing two temporary RISC cofactors from magnesium-rich hairpins and/or pseud

259 with hAgo2 before small RNA loading and that RISC loading takes place in the cytoplasm rather than in

260 We find that RISC readily tolerates insertions of up to 7 nt in its t

261 We propose that RISC-mediated inhibition of specific sets of chromatin r

262 Furthermore, we show that RISC-recycling determines the effect that Argonaute scar

263 interaction with either Ago1 or Ago2 and the RISC-loading complex.

264 At the RISC core is one Argonaute (AGO) protein that, guided by

265 cruitment of additional proteins to form the RISC.

266 With 1,004 nondiabetic individuals from the RISC study, we performed a genome-wide association study

267 g of target transcripts and are found in the RISC complex as demonstrated by their interaction with A

268 iRNAs and mRNAs are actively targeted in the RISC, indicating that PAR-CLIP more accurately defines m

269 sequences which upon incorporation into the RISC ribonucleoprotein complex, play a crucial role in r

270 o revealed that HSV-1 miRNAs loaded into the RISC with efficiencies that differed widely; <1% of the

271 r the loading of microRNAs (miRNAs) into the RISC, and translocation to stress granules (SGs).

272 iR-H11, were found to actually load into the RISC.

273 in HSV-1-infected cells was loaded into the RISC.

274 ing complex (RISC) requires formation of the RISC loading complex (RLC), which contains the Dicer-2 (

275 e show that depletion of key proteins of the RISC pathway by antisense oligonucleotides significantly

276 ese findings deepen the understanding of the RISC process in TADF materials.

277 Furthermore, each of the RISC proteins, together with Argonaute 2, associates wit

278 hat Drosophila AGO1 functions outside of the RISC to repress Myc transcription and inhibit developmen

279 plex) followed by microarray analysis of the RISC-bound miRNA targets (RIP-Chip) to evaluate the rela

280 (SSB)/autoantigen La as an activator of the RISC-mediated mRNA cleavage activity.

281 istent with it also being a component of the RISC.

282 ever, involve canonical roles as part of the RISC; rather, AGO1 controls cell and tissue growth by fu

283 This 16-bit microprocessor is based on the RISC-V instruction set, runs standard 32-bit instruction

284 encing complex (RISC) and its precursor, the RISC loading complex (RLC), is a key step in the RNA int

285 TRBP, are sufficient for reconstituting the RISC complex in vitro.

286 HSP90, which has been shown to stabilize the RISC, are novel host proteins that regulate HCV infectio

287 tiviral response, others have found that the RISC complex that facilitates miRNA-mediated silencing i

288 These results show that the RISC process is not governed by the hyperfine interactio

289 Here, we found that the RISC protein MOV10 was present at synapses and was rapid

290 se in binding of let-7 family members to the RISC complex is functional.

291 ntain microRNAs (miRNAs) associated with the RISC-Loading Complex (RLC) and display cell-independent

292 not the miR-133 family, by disrupting their RISC association.

293 affecting the susceptibility of TCV-rev1 to RISC loaded with viral small RNAs.

294 owed that La could promote multiple-turnover RISC catalysis by facilitating the release of cleaved mR

295 Results from unbiased RISC-trap screens, in vivo reporter assays and overexpre

296 ervoirs of microRNAs in low molecular weight RISC (LMW-RISC) not bound to mRNA, suggesting that these

297 changes in miRNAs and mRNAs associated with RISC, thereby altering post-transcriptional regulation o

298 ractions enhance viral mRNA association with RISC and P body proteins.

299 ere we report that HIV-1 mRNA interacts with RISC proteins and that disrupting P body structures enha

300 eracts with Ago1 and processes miR-34 within RISC.